Latest News about AZN
Recent news which mentions AZN
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
3 Best Biotech Stocks to Buy in November
November 08, 2021
From Motley Fool
Better Buy After Earnings: Moderna or Novavax?
November 08, 2021
From Motley Fool
These Clinical Results Are Good News for AstraZeneca
November 06, 2021
From Motley Fool
Handbag wars? Chanel price hikes rally luxury goods makers in Europe
November 05, 2021
From MarketWatch
Novavax Looks Primed and Ready for a Vaccine Comeback
November 04, 2021
From InvestorPlace
Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32
November 03, 2021
From InvestorPlace
PhaseBio's Bentracimab Reverses Ticagrelor-Associated Antiplatelet Activity In Mid-Stage Study
November 03, 2021
From Benzinga
The 1 Thing I'll be Looking for in Novavax's Earnings Report
November 03, 2021
From Motley Fool
From Benzinga
AstraZeneca To Offload Some Drug Rights To Covis Pharma For $270M
November 01, 2021
From Benzinga
From InvestorPlace
4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin
November 01, 2021
From InvestorPlace
Novavax Just Caught a Big Break
October 29, 2021
From InvestorPlace
From Motley Fool
From Benzinga
NVAX Stock Soars 6% as Novavax Reaches Key Vaccine Milestone
October 27, 2021
From InvestorPlace
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
AstraZeneca's Imfinzi/Chemo Combo Strikes First Immunotherapy Wins In Bile Duct Cancer Trial
October 26, 2021
From Benzinga
Novavax is Now a Riskier Play, but Still One to Keep Your Eye On
October 25, 2021
From InvestorPlace
From Motley Fool
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
October 22, 2021
From Motley Fool
7 Penny Stocks to Buy to Sidestep the Noise on Wall Street
October 21, 2021
From InvestorPlace
2 COVID Stocks I'd Consider Instead of Moderna
October 21, 2021
From Motley Fool
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
From Benzinga
Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
October 20, 2021
From Motley Fool
From Benzinga
From Benzinga
U.S. may soon authorize boosters for all 3 in-use vaccines, as experts renew plea for unvaccinated to get their shots
October 18, 2021
From MarketWatch
These 2 Nasdaq Biotechs Are Making Huge Premarket Moves Monday
October 18, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.